256 related articles for article (PubMed ID: 10467652)
1. [Implantation of a dual chamber pacemaker-defibrillator (DDD-ICD) in a patient with hypertrophic obstructive cardiomyopathy].
Neuberger HR; Mewis C; Dörnberger V; Bosch RF; Kühlkamp V
Z Kardiol; 1999 Jul; 88(7):521-5. PubMed ID: 10467652
[TBL] [Abstract][Full Text] [Related]
2. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
[TBL] [Abstract][Full Text] [Related]
3. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.
Park MH; Gilligan DM; Bernardo NL; Topaz O
Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
7. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
[TBL] [Abstract][Full Text] [Related]
8. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
Nishimura RA; Trusty JM; Hayes DL; Ilstrup DM; Larson DR; Hayes SN; Allison TG; Tajik AJ
J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001
[TBL] [Abstract][Full Text] [Related]
9. Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000.
Erwin JP; Nishimura RA; Lloyd MA; Tajik AJ
Mayo Clin Proc; 2000 Feb; 75(2):173-80. PubMed ID: 10683657
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L
Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
[TBL] [Abstract][Full Text] [Related]
12. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
13. [Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm and sustained ventricular tachycardia: a case report].
Kono K; Higashi T; Hara K; Mori S; Ito I; Shinbo G; Anzai R; Yagi H; Tamano K; Horinaka S; Matsuoka H
J Cardiol; 2001 Dec; 38(6):343-9. PubMed ID: 11806092
[TBL] [Abstract][Full Text] [Related]
14. Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy.
Honda T; Shono H; Koyama J; Tsuchiya T; Hayashi M; Hirayama T; Uesugi H; Honda T
Circ J; 2005 May; 69(5):536-42. PubMed ID: 15849439
[TBL] [Abstract][Full Text] [Related]
15. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
[TBL] [Abstract][Full Text] [Related]
17. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
[TBL] [Abstract][Full Text] [Related]
18. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
[TBL] [Abstract][Full Text] [Related]
19. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
20. Management of hypertrophic cardiomyopathy in children.
Seggewiss H; Rigopoulos A
Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
